Find Capmatinib Hydrochloride manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1865733-40-9, Nvp-inc280-aaa, Capmatinib hydrochloride [usan], C2a374o70x, Capmatinib (dihydrochloride hydrate), Tabrecta
Molecular Formula
C23H21Cl2FN6O2
Molecular Weight
503.4  g/mol
InChI Key
COWBUPJEEDYWKD-UHFFFAOYSA-N
FDA UNII
C2A374O70X

Capmatinib Hydrochloride
Capmatinib Hydrochloride is the hydrochloride salt form of capmatinib, an orally bioavailable inhibitor of the proto-oncogene c-Met (also known as hepatocyte growth factor receptor (HGFR)) with potential antineoplastic activity. Capmatinib selectively binds to c-Met, thereby inhibiting c-Met phosphorylation and disrupting c-Met signal transduction pathways. This may induce cell death in tumor cells overexpressing c-Met protein or expressing constitutively activated c-Met protein. c-Met, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays key roles in tumor cell proliferation, survival, invasion, metastasis, and tumor angiogenesis.
1 2D Structure

Capmatinib Hydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide;hydrate;dihydrochloride
2.1.2 InChI
InChI=1S/C23H17FN6O.2ClH.H2O/c1-25-22(31)18-6-5-16(11-19(18)24)21-13-28-23-27-12-17(30(23)29-21)10-14-4-7-20-15(9-14)3-2-8-26-20;;;/h2-9,11-13H,10H2,1H3,(H,25,31);2*1H;1H2
2.1.3 InChI Key
COWBUPJEEDYWKD-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F.O.Cl.Cl
2.2 Other Identifiers
2.2.1 UNII
C2A374O70X
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-fluoro-4-(7-((quinolin-6-yl)methyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)benzoic Acid

2. 2-fluoro-4-(7-((quinolin-6-yl)methyl)imidazo(1,2-b)-(1,2,4)triazin-2-yl)benzamide

3. 2-fluoro-n-methyl-4-(7-((quinolin-6-yl)methyl)imidazo(1,2- B)(1,2,4)triazin-2-yl)benzamide Dihydrochloride Monohydrate

4. 2-fluoro-n-methyl-4-(7-(quinolin-6-yl-methyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)benzamide

5. 2-fluoro-n-methyl-4-(7-(quinolin-6-ylmethyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)benzamide

6. 2-fluoro-n-methyl-4-(7-(quinolin-6-ylmethyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)benzamide Dihydrochloride

7. Capmatinib

8. Capmatinib Dihydrochloride

9. Capmatinib Dihydrochloride Monohydrate

10. Capmatinib Hydrochloride Anhydrous

11. Capmatinib Metabolite M13

12. Capmatinib Metabolite M18

13. Cmc-583

14. Cmc583

15. Cnj-294

16. Cnj294

17. Inc-280

18. Inc280

19. Incb-28060

20. Incb-28060 Free Base

21. Incb28060

22. Nvp-inc280

23. Nvp-inc280-nx

24. Tabrecta

2.3.2 Depositor-Supplied Synonyms

1. 1865733-40-9

2. Nvp-inc280-aaa

3. Capmatinib Hydrochloride [usan]

4. C2a374o70x

5. Capmatinib (dihydrochloride Hydrate)

6. Tabrecta

7. Capmatinib Dihydrochloride Monohydrate

8. Capmatinib Hydrochloride (usan)

9. Capmatinib Hydrochloride Hydrate (jan)

10. 2-fluoro-n-methyl-4-(7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl)benzamide Dihydrochloride Hydrate

11. Capmatinib Hydrochloride Hydrate [jan]

12. Tabrecta (tn)

13. Capmatinib 2hcl.h2o

14. Capmatinib 2hcl Hydrate

15. Inc-280 Hydrochloride

16. Incb28060 Hydrochloride

17. Unii-c2a374o70x

18. Capmatinib Hydrochloride Hydrate

19. Chembl3989937

20. Dtxsid401027869

21. Hy-13404c

22. Capmatinib Hydrochloride [who-dd]

23. Capmatinib Hydrochloride Monohydrate

24. Cs-0198834

25. Capmatinib Hydrochloride [orange Book]

26. D10891

27. Q27895918

28. 2-fluoro-n-methyl-4-(7-((quinolin-6-yl)methyl)imidazo(1,2- B)(1,2,4)triazin-2-yl)benzamide Dihydrochloride Monohydrate

29. Benzamide, 2-fluoro-n-methyl-4-(7-(6-quinolinylmethyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)-, Hydrochloride, Hydrate (1:2:1)

2.4 Create Date
2016-11-15
3 Chemical and Physical Properties
Molecular Weight 503.4 g/mol
Molecular Formula C23H21Cl2FN6O2
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count7
Rotatable Bond Count4
Exact Mass502.1087075 g/mol
Monoisotopic Mass502.1087075 g/mol
Topological Polar Surface Area86.1 Ų
Heavy Atom Count34
Formal Charge0
Complexity637
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count4
4 Drug and Medication Information
4.1 Drug Indication

Tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (NSCLC) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (METex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.


5 Pharmacology and Biochemistry
5.1 ATC Code

L01EX17


Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Capmatinib Hydrochloride Manufacturers

A Capmatinib Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Capmatinib Hydrochloride, including repackagers and relabelers. The FDA regulates Capmatinib Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Capmatinib Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Capmatinib Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Capmatinib Hydrochloride Suppliers

A Capmatinib Hydrochloride supplier is an individual or a company that provides Capmatinib Hydrochloride active pharmaceutical ingredient (API) or Capmatinib Hydrochloride finished formulations upon request. The Capmatinib Hydrochloride suppliers may include Capmatinib Hydrochloride API manufacturers, exporters, distributors and traders.

click here to find a list of Capmatinib Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Capmatinib Hydrochloride USDMF

A Capmatinib Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Capmatinib Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Capmatinib Hydrochloride DMFs exist exist since differing nations have different regulations, such as Capmatinib Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Capmatinib Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Capmatinib Hydrochloride USDMF includes data on Capmatinib Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Capmatinib Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Capmatinib Hydrochloride suppliers with USDMF on PharmaCompass.

Capmatinib Hydrochloride NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Capmatinib Hydrochloride as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Capmatinib Hydrochloride API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Capmatinib Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Capmatinib Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Capmatinib Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Capmatinib Hydrochloride suppliers with NDC on PharmaCompass.

Capmatinib Hydrochloride GMP

Capmatinib Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Capmatinib Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Capmatinib Hydrochloride GMP manufacturer or Capmatinib Hydrochloride GMP API supplier for your needs.

Capmatinib Hydrochloride CoA

A Capmatinib Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Capmatinib Hydrochloride's compliance with Capmatinib Hydrochloride specifications and serves as a tool for batch-level quality control.

Capmatinib Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Capmatinib Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Capmatinib Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Capmatinib Hydrochloride EP), Capmatinib Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Capmatinib Hydrochloride USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty